Casi Pharmaceuticals Inc Reports Results For The Quarter Ended In June: Earnings Summary

CASI Pharmaceuticals

12/08/2022 14:31

* CASI Pharmaceuticals Inc  CASI.OQ  reported a quarterly
adjusted
loss of 56 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 64 cents per share.
    * Revenue rose 19.7% to $8.57 million from a year ago;
analysts
expected $7.88 million. 
    * CASI Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 56 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * CASI Pharmaceuticals Inc shares had risen by 36.4% this
quarter and lost 51.2% so far this year.
    * The company reported a quarterly loss of $7.68 million.
    * Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $30.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 12
at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.64          -0.56          Beat
 Mar. 31 2022      -0.87          -0.60          Beat
 Dec. 31 2021      -0.57          -0.40          Beat
 Sep. 30 2021      -0.55          -0.70          Missed